학술논문

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence
Document Type
Article
Source
In Oral Oncology December 2023 147
Subject
Language
ISSN
1368-8375